Host cell and expression engineering for development of an E. coli ketoreductase catalyst: Enhancement of formate dehydrogenase activity for regeneration of NADH

Microbial Cell Factories

Volumn 11, Issue , 2012, Pages

  Mädje, Katharina ^a   Schmölzer, Katharina ^a   Nidetzky, Bernd ^a   Kratzer, Regina ^a  

^a GRAZ UNIVERSITY OF TECHNOLOGY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2 CHLOROPHENYL)ETHANOL; ALCOHOL DERIVATIVE; BACTERIAL ENZYME; CANDIDA TENUIS XYLOSE REDUCTASE; ESCHERICHIA COLI KETOREDUCTASE; FORMATE DEHYDROGENASE; FUNGAL ENZYME; PHENACYL CHLORIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; TRANSFER RNA; UNCLASSIFIED DRUG; XYLITOL; XYLOSE; ALDEHYDE REDUCTASE; NICOTINAMIDE ADENINE DINUCLEOTIDE; RECOMBINANT PROTEIN;

ARTICLE; BACTERIAL STRAIN; BIOCATALYST; CANDIDA; CANDIDA BOIDINII; CANDIDA TENUIS; CATALYST; ENZYME ACTIVITY; ENZYME ENGINEERING; ESCHERICHIA COLI; EXPRESSION ENGINEERING; GENE DOSAGE; HOST CELL; LOW TEMPERATURE; NONHUMAN; PROTEIN EXPRESSION; SYNTHESIS; WHOLE CELL; BIOCATALYSIS; BIOSYNTHESIS; ENZYMOLOGY; GENETICS; METABOLISM; PROTEIN ENGINEERING;

CANDIDA BOIDINII; CANDIDA TENUIS; ESCHERICHIA COLI;

ALDEHYDE REDUCTASE; BIOCATALYSIS; CANDIDA; ESCHERICHIA COLI; FORMATE DEHYDROGENASES; NAD; OMEGA-CHLOROACETOPHENONE; PROTEIN ENGINEERING; RECOMBINANT PROTEINS;

EID: 84857031457     PISSN: None     EISSN: 14752859     Source Type: Journal    
DOI: 10.1186/1475-2859-11-7     Document Type: Article

References (23)

1. Tishkov VI, Popov VO. Protein engineering of formate dehydrogenase. Biomol Eng 2006, 23:89-110. 10.1016/j.bioeng.2006.02.003, 16546445.
2. Bommarius AS, Schwarm M, Stingl K, Kottenhahn M, Huthmacher K, Drauz K. Synthesis and use of enantiometrically pure tert-leucine. Tetrahedron Asymmetry 1995, 6:2851-2888.
3. Kratzer R, Pukl M, Egger S, Nidetzky B. Whole-cell bioreduction of aromatic α-keto esters using Candida tenuis xylose reductase and Candida boidinii formate dehydrogenase co-expressed in Escherichia coli. Microb Cell Fact 2008, 7:37-48. 10.1186/1475-2859-7-37, 2637230, 19077192.
4. Kratzer R, Pukl M, Egger S, Vogl M, Brecker L, Nidetzky B. Enzyme identification and development of a whole-cell biotransformation for asymmetric reduction of o-chloroacetophenone. Biotech Bioeng 2011, 101:1094-1101.
5. Weckbecker A, Hummel W. Improved synthesis of chiral alcohols with Escherichia coli cells co-expressing pyridine nucleotide transhydrogenase, NADP+-dependent alcohol dehydrogenase and NAD+-dependent formate dehydrogenase. Biotechnol Letters 2004, 26:1739-1744.
6. Gröger H, May O, Werner H, Menzel A, Altenbuchner J. A 'second-generation process' for the synthesis of L-neopentylglycine: Asymmetric reductive amination using a recombinant whole cell catalyst. Org Process Res Dev 2006, 10:666-669.
7. Baneyx F. Recombinant protein expression in Escherichia coli. Curr Opin Biotechnol 1999, 10:411-421. 10.1016/S0958-1669(99)00003-8, 10508629.
8. Krahulec S, Armao GC, Weber H, Nidetzky B. Characterization of recombinant Aspergillus fumigatus mannitol-1-phosphate 5-dehydrogenase and its application for the stereoselective synthesis of protio and deuterio forms of D-mannitol 1-phosphate. Carbohydr Res 2008, 9:1414-1423.
9. Sørensen HP, Mortensen KK. Advanced genetic strategies for recombinant protein expression in Escherichia coli. J Biotechnol 2005, 115:113-128. 10.1016/j.jbiotec.2004.08.004, 15607230.
10. E. coli genotypes from http://openwetware.org/wiki/E._coli_genotypes.
11. Iost I, Dreyfus M. The stability of Escherichia coli lacZ mRNA depends upon the simultaneity of its synthesis and translation. EMBO J 1995, 14:3252-3261. 394387, 7542588.
12. Régnier P, Arraiano CM. Degradation of mRNA in bacteria: Emergence of ubiquitous features. BioEssay 2000, 22:235-244.
13. Makrides SC. Strategies for achieving high-level expression of genes in Escherichia coli. Microbiol Mol Biol Rev 1996, 60:512-538.
14. Rare Codon Calculator (RaCC) from http://nih.mbi.ucla.edu/ at the UCLA.
15. Häcker B, Habenicht A, Kiess M, Mattes R. Xylose utilisation: Cloning and characterisation of the xylose reductase from Candida tenuis. Biol Chem 1999, 12:1395-1403.
16. Novy R, Yaeger K, Held D, Mierendorf R. Coexpression of multiple target proteins in E. coli. inNovations 2002, 15:2-6.
17. Menzel A, Werner H, Altenbucher J, Gröger H. From enzymes to "designer bugs" in reductive amination: A new process for the synthesis of L-tert-leucine using a whole cell-catalyst. Eng Life Sci 2004, 4:573-576.
18. Santamaria A, Neef R, Eberspächer U, Eis K, Husemann M, Mumberg D, Prechtl S, Schulze V, Siemeister G, Wortmann L, Barr FA, Nigg EA. Use of the novel Plk1 inhibitor ZK-thiazolidinone to elucidate functions of Plk1 in early and late stages of mitosis. Mol Biol Cell 2007, 18:4024-4036. 10.1091/mbc.E07-05-0517, 1995727, 17671160.
19. Sato Y, Onozaki Y, Sugimoto T, Kurihara H, Kamijo K, Kadowaki C, Tsujino T, Watanabe A, Otsuki S, Mitsuya M, Iida M, Haze K, Machida T, Nakatsuru Y, Komatani H, Kotani H, Iwasawa Y. Imidazopyridine derivatives as potent and selective Polo-like kinase (PLK) inhibitors. Bioorg Med Chem Lett 2009, 19:4673-4678. 10.1016/j.bmcl.2009.06.084, 19589677.
20. Rheault TR, Donaldson KH, Badiang-Alberti JG, Davis-Ward RG, Andrews CW, Bambal R, Jackson JR, Cheung M. Heteroaryl-linked 5-(1H-benzimidazol-1-yl)-2-thiophenecarboxamides: Potent inhibitors of polo-like kinase 1 (PLK1) with improved drug-like properties. Bioorg Med Chem Lett 2010, 20:4587-4592. 10.1016/j.bmcl.2010.06.009, 20594842.
21. Kaup B, Bringer-Meyer S, Sahm H. Metabolic engineering of Escherichia coli: construction of an efficient biocatalyst for D-mannitol formation in a whole-cell biotransformation. Appl Microbiol Biotechnol 2004, 64:333-339. 10.1007/s00253-003-1470-9, 14586579.
22. Alphand V, Carrea G, Wohlgemuth R, Furstoss R, Woodley JM. Towards large-scale synthetic applications of Baeyer-Villiger monooxygenases. Trends Biotechnol 2003, 21:318-323. 10.1016/S0167-7799(03)00144-6, 12837617.
23. Doig SD, Avenell PJ, Bird PA, Gallati P, Lander KS, Lye GJ, Wohlgemuth R, Woodley JM. Reactor operation and scale-up of whole cell Baeyer-Villiger catalyzed lactone synthesis. Biotechnol Prog 2002, 18:1039-1046. 10.1021/bp0200954, 12363355.